Curis reported $6.74M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alaunos Therapeutics USD 732K 332K Jun/2026
Amgen USD 20.83B 17.97B Sep/2026
AstraZeneca USD 23.57B 679M Sep/2026
Bayer EUR 6.71B 314M Sep/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
CSL USD 3.17B 290M Dec/2025
Curis USD 6.74M 1.13M Mar/2026
Eli Lilly USD 5.79B 319M Sep/2026
Exelixis USD 30.83M 8.23M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Merck USD 5.03B 1.2B Sep/2026
Novartis USD 4.24B 15M Sep/2026
Pfizer USD 4.07B 511M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 24.55B 957M Sep/2026
Takeda JPY 486.2B 39.41B Sep/2026
TG Therapeutics USD 176.86M 36.83M Sep/2026
Verastem USD 9.6M 2.85M Mar/2026